All Stories

  1. Empirical Bayes estimators in hierarchical models with mixture priors

    Article • Journal of Applied Statistics, March 2018, Taylor & Francis

    Dr Gerd K Rosenkranz

  2. Estimands-new statistical principle or the emperor's new clothes?

    Article • Pharmaceutical Statistics, December 2016, Wiley

    Dr Gerd K Rosenkranz

  3. Exploratory subgroup analyses

    Article • Biometrical Journal, May 2016, Wiley

    Dr Gerd K Rosenkranz

  4. Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study

    Article • Journal of Neurodevelopmental Disorders, December 2015, Springer Science + Business Media

    Dr Gerd K Rosenkranz

  5. Bootstrap corrections of treatment effect estimates following selection

    Article • Computational Statistics & Data Analysis, January 2014, Elsevier

    Dr Gerd K Rosenkranz

  6. Missing Data in Noninferiority Trials

    Article • Statistics in Biopharmaceutical Research, November 2013, Taylor & Francis

    Brian Wiens, Dr Gerd K Rosenkranz

  7. The impact of randomization on the analysis of clinical trials

    Article • Statistics in Medicine, September 2011, Wiley

    Dr Gerd K Rosenkranz

  8. Adaptive design theory and implementation using SAS and R Mark Chang (2007) ISBN 1584889624; 440 pages; £48.99, $89.95 Chapman & Hall/CRC; http://www.crcpress.com

    Article • Pharmaceutical Statistics, March 2011, Wiley

    Dr Gerd K Rosenkranz

  9. Joint Modeling of Outcome, Observation Time, and Missingness

    Article • Journal of Biopharmaceutical Statistics, February 2011, Taylor & Francis

    Dr Gerd K Rosenkranz

  10. Another view on the analysis of cardiovascular morbidity/mortality trials

    Article • Pharmaceutical Statistics, April 2010, Wiley

    Dr Gerd K Rosenkranz

  11. A note on the Hodges-Lehmann estimator

    Article • Pharmaceutical Statistics, August 2009, Wiley

    Dr Gerd K Rosenkranz

  12. Modeling laboratory data from clinical trials

    Article • Computational Statistics & Data Analysis, January 2009, Elsevier

    Dr Gerd K Rosenkranz

  13. Hypothesis

    Article • December 2007, Wiley

    Dr Gerd K Rosenkranz

  14. Modeling laboratory data from clinical trials

    Article • PAMM, December 2007, Wiley

    Dr Gerd K Rosenkranz

  15. A Note on Ethnic Sensitivity Studies

    Article • Journal of Biopharmaceutical Statistics, January 2006, Taylor & Francis

    Dr Gerd K Rosenkranz

  16. Comments on ???Effects of Interrater Reliability of Psychopathologic Assessment on Power and Sample Size Calculations in Clinical Trials??? by Muller and Associates

    Article • Journal of Clinical Psychopharmacology, December 2003, Wolters Kluwer Health

    Dr Gerd K Rosenkranz

  17. Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia

    Article • The Hematology Journal, November 2000, Nature

    Dr Gerd K Rosenkranz

  18. Can we reduce the dose of a vaccine?

    Article • Controlled Clinical Trials, February 1997, Elsevier

    Dr Gerd K Rosenkranz

  19. A Limit Theorem for Measure Valued Diffusion Processes

    Article • January 1988, Springer Science + Business Media

    Dr Gerd K Rosenkranz

  20. Growth models with stochastic differential equations. an example from tumor immunology

    Article • Mathematical Biosciences, August 1985, Elsevier

    Dr Gerd K Rosenkranz

  21. Diffusion approximation of controlled branching processes with random environments

    Article • Stochastic Analysis and Applications, January 1985, Taylor & Francis

    Dr Gerd K Rosenkranz

  22. On global stability of discrete population models

    Article • Mathematical Biosciences, June 1983, Elsevier

    Dr Gerd K Rosenkranz

  23. On the presistence of tumor initiation in two-stage carcinogenesis on mouse skin

    Article • Carcinogenesis, January 1983, Oxford University Press (OUP)

    Dr Gerd K Rosenkranz

  24. APL-Programs for the analysis of carcinogenicity experiments

    Article • Computer Programs in Biomedicine, October 1982, Elsevier

    Dr Gerd K Rosenkranz

  25. Stochastic measure diffusions as models of growth and spread

    Article • Springer Science + Business Media

    Dr Gerd K Rosenkranz